Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Squamous Cell Carcinoma of Head and Neck × Gabapentin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hot Flashes 6 Head and Neck Neoplasms 6 Breast Neoplasms 5 Pain, Postoperative 3 Prostatic Neoplasms 2 Pain 2 Neuralgia 2 Mucositis 2 Depression 2 Vomiting 1 Urinary Bladder Neoplasms 1 Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Psychotic Disorders 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Oropharyngeal Neoplasms 1 Neurotoxicity Syndromes 1 Neoplasms 1 Nausea 1 Myalgia 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Laryngeal Diseases 1 Ileus 1 Glioblastoma 1 Epilepsy 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1 Constipation 1

Interventions

Cisplatin 240 pembrolizumab 203 Radiotherapy 147 Cetuximab 147 Carboplatin 110 Docetaxel 98 Paclitaxel 87 Fluorouracil 81 Nivolumab 78 Radiotherapy, Intensity-Modulated 71 durvalumab 32 Magnetic Resonance Spectroscopy 31 Radiation 29 Drug Therapy 29 Biopsy 26 Surgical Procedures, Operative 24 Erlotinib Hydrochloride 22 Immunohistochemistry 21 Albumin-Bound Paclitaxel 21 Taxes 20 Specimen Handling 19 Radiosurgery 19 130-nm albumin-bound paclitaxel 19 toripalimab 18 Platinum 17 Ipilimumab 17 tremelimumab 16 tislelizumab 16 Gemcitabine 16 Bevacizumab 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06992427 2026-03-04

HOPE

Alliance for Clinical Trials in Oncology

Phase 3 Recruiting

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon ⚡